Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III–IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus

Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III–IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus

Qian Zhao,1,2 Shanshan Fan,1,2 Yu Chang,1,2 Xiyang Liu,1,2 Wencai Li,2,3 Qianwen Ma,1,2 Yang Li,1,2 Yan Wang,1,2 Lei Zhang,1,2,* Mingzhi Zhang1,2,*1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, People’s Republic of China; 2Lymphoma...

Full description

Bibliographic Details
Main Authors: Zhao Q, Fan S, Chang Y, Liu X, Li W, Ma Q, Li Y, Wang Y, Zhang L, Zhang M
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Cancer Management and Research
Subjects:
Gemcitabine
Pegaspargase
Extranodal NK/T-cell lymphoma
Epstein-Barr virus (EBV)-DNA
Prognosis
Online Access:https://www.dovepress.com/clinical-efficacy-of-cisplatin-dexamethasone-gemcitabine-and-pegasparg-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/clinical-efficacy-of-cisplatin-dexamethasone-gemcitabine-and-pegasparg-peer-reviewed-article-CMAR

Similar Items